IsoPlexis

IsoPlexis is a Connecticut-based single-cell detection platform that provides solutions including predicting disease progression and treatment resistance for researchers.

Business Model:

Revenue: $18.9M

Employees: 201-500

Detailed IsoPlexis Information

Geographic Data

IsoPlexis headquarters map

Address: 35 NE Industrial Road

City: Branford

State: CT

Zip: 06405

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$125M

Raised Total:

$317M

Metrics

3,602,854Website Global Rank

3,724Website Monthly Traffic

Twitter Followers

Description

IsoPlexis is a Connecticut-based single-cell detection platform that provides solutions including predicting disease progression and treatment resistance for researchers.

Contact Phone:
+12032084111

Contact Email:

IsoPlexis went public on 10/8/2021 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
10/8/2021

IPO Valuation:
$583M

Ticker Symbol:
ISO

IPO Price:
$15/share

Amount Raised:
$125M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
1/2021 Series D $135M Perceptive Advisors
Ally Bridge Group
BlackRock
10/2021 Post-IPO Equity $125M
11/2016 Series B 1 - Advantage Capital
Advantage Capital
5/2015 Seed Round $2.4M
10/2019 Grant 1 $2M National Cancer Institute SBIR Development Center
National Cancer Institute SBIR Development Center
1/2020 Series C $0 Spring Mountain Capital
Northpond Ventures
Connecticut Innovations
Northpond Ventures
Advantage Capital
Ironwood Capital
North Sound Capital
Spring Mountain Capital
Northpond Ventures
Connecticut Innovations
Northpond Ventures
Advantage Capital
Ironwood Capital
North Sound Capital
9/2017 Series B 5 $13.5M Spring Mountain Capital
North Sound Ventures
Ironwood Capital
Connecticut Innovations
Advantage Capital
Spring Mountain Capital
8/2014 Series A 2 $1.3M Spring Mountain Capital
Connecticut Innovations
Spring Mountain Capital
Connecticut Innovations
5/2019 Series C $0 Northpond Ventures
Ironwood Capital
Advantage Capital
Connecticut Innovations
North Sound Capital
Spring Mountain Capital
Northpond Ventures
Ironwood Capital
Advantage Capital
Connecticut Innovations
North Sound Capital
Spring Mountain Capital
1/2021 Debt Financing 3 $50M BlackRock
Ally Bridge Group
Perceptive Advisors
Perceptive Advisors
BlackRock
Ally Bridge Group
Perceptive Advisors
Perceptive Advisors
1/2021 Series D 3 $85M Perceptive Advisors
Ally Bridge Group
BlackRock
Perceptive Advisors
Perceptive Advisors
Ally Bridge Group
BlackRock
Perceptive Advisors
10/2021 IPO $100M
6/2019 Grant 1 $4M National Cancer Institute SBIR Development Center
National Cancer Institute SBIR Development Center
12/2019 Series C 1 -
8/2014 Seed Round $0 Connecticut Innovations
YEI Innovation Fund
Connecticut Innovations
YEI Innovation Fund
6/2020 Grant 1 $2M National Institute on Aging
National Institute on Aging
National Institute on Aging
National Institute on Aging
1/2020 Series C 6 $20M Northpond Ventures
Spring Mountain Capital
Northpond Ventures
Connecticut Innovations
Northpond Ventures
12/2019 Series C 1 -
5/2019 Series C 6 $25M Northpond Ventures
Northpond Ventures
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research